```html

Glomerular Hematuria

What is Glomerular hematuria?

Glomerular hematuria is the presence of red blood cells (RBCs) in the urine that originate from the glomeruli – the tiny filtering units of the kidneys. Unlike “non‑glomerular” or lower‑tract bleeding (which often produces clear, bright‑red urine), glomerular bleeding typically yields microscopic hematuria or urine that looks “tea‑colored” or “cola‑colored” because the blood has been altered as it passes through the renal filtration barrier.

The glomerulus consists of capillaries lined by a delicate basement membrane and podocytes. Damage to any of these components allows RBCs to leak into the Bowman’s space and then into the urine. Because the same structural injury often lets proteins escape, glomerular hematuria is frequently accompanied by proteinuria and can be an early sign of chronic kidney disease (CKD).

Key points:

• Can be microscopic (detected only on lab testing) or gross (visible to the eye).
• Often associated with an abnormal urine sediment – dysmorphic RBCs, RBC casts, and sometimes red‑cell “acanthocytes.”
• May signal an acute inflammatory process (e.g., glomerulonephritis) or a chronic disease (e.g., IgA nephropathy).

Sources: Mayo Clinic, National Kidney Foundation, KDIGO Guidelines.

Common Causes

Glomerular hematuria is a manifestation of underlying kidney pathology. Below are the most frequent conditions that produce this finding:

• IgA Nephropathy (Berger disease) – the most common primary glomerulonephritis worldwide, often presenting with episodic hematuria after upper‑respiratory infections.
• Post‑infectious glomerulonephritis – follows streptococcal throat or skin infections; classic “cola‑colored” urine.
• Alport syndrome – hereditary basement‑membrane disorder; hematuria appears in childhood and progresses to CKD.
• Lupus nephritis – systemic lupus erythematosus involving the kidneys; can cause both hematuria and heavy proteinuria.
• Membranous nephropathy – usually presents with proteinuria, but RBCs may appear when the disease is active.
• ANCA‑associated vasculitis (e.g., microscopic polyangiitis, granulomatosis with polyangiitis) – small‑vessel inflammation that damages glomeruli.
• Thin basement membrane disease (TBMD) – benign cause of persistent microscopic hematuria, especially in families.
• Hereditary complement‑mediated diseases (e.g., C3 glomerulopathy, atypical hemolytic‑uremic syndrome).
• Kidney transplant rejection – acute or chronic rejection can provoke glomerular bleeding.
• Drugs & toxins – certain antibiotics (e.g., penicillins), NSAIDs, or heavy metals can incite an immune response causing glomerulonephritis.

Associated Symptoms

Because glomerular injury often affects more than just the filtration barrier, patients may notice additional signs:

• Proteinuria – frothy urine or a measurable increase in urinary protein.
• Edema – swelling of the ankles, feet, or face, especially after prolonged standing.
• Hypertension – high blood pressure due to sodium retention and renin‑angiotensin activation.
• Flank or kidney pain – less common but can occur with rapidly progressive GN.
• Reduced urine output – in severe cases leading toward acute kidney injury.
• Systemic features – fever, rash, joint pains, or malaise when the underlying cause is autoimmune or infectious.
• Fatigue or malaise – secondary to anemia from chronic blood loss or kidney dysfunction.

When to See a Doctor

While a single episode of microscopic hematuria may be harmless, the following situations warrant prompt medical evaluation:

• Visible (gross) blood in the urine, especially if the urine is dark, cola‑colored, or has clots.
• Persistent hematuria that lasts more than a few days or recurs.
• Accompanying symptoms such as swelling, uncontrolled high blood pressure, or decreased urine output.
• Recent history of a strep throat, skin infection, or respiratory illness.
• Known kidney disease, autoimmune disease, or a family history of hereditary kidney disorders.
• New onset of proteinuria (≥1 g/day) or a rapid rise in serum creatinine.

Early evaluation can prevent progression to chronic kidney disease.

Diagnosis

Diagnosing glomerular hematuria involves confirming that the blood originates from the kidney's filtering units and then identifying the underlying cause.

1. Urinalysis

• Microscopy – looking for dysmorphic RBCs, RBC casts, and presence of protein.
• Dipstick testing – provides rapid screening for blood, protein, and leukocytes.

2. Laboratory Tests

• Serum creatinine & eGFR – evaluate kidney function.
• Urine protein quantification – 24‑hour collection or spot urine protein‑to‑creatinine ratio.
• Complement levels (C3, C4) – low levels suggest immune‑complex disease.
• Serologic panels – ANA, anti‑DNA, ANCA, anti‑GBM, anti‑streptolysin O (ASO) titers, hepatitis B/C, HIV.

3. Imaging

• Renal ultrasound – rules out structural obstruction, cysts, or hydronephrosis.
• CT or MRI – reserved for atypical cases or when a renal mass is suspected.

4. Kidney Biopsy

When non‑invasive tests cannot pinpoint the etiology, a percutaneous renal biopsy provides definitive histologic diagnosis. It helps classify the type of glomerulonephritis, determines activity vs. chronic scarring, and guides therapy.

5. Genetic Testing

Indicated for suspected hereditary conditions (e.g., Alport syndrome, TBMD, C3 glomerulopathy). Panels target COL4A3‑5, CFHR5, and complement‑regulatory genes.

Treatment Options

Treatment is two‑fold: managing the underlying cause and protecting remaining kidney function.

1. Disease‑Specific Therapies

• IgA Nephropathy – supportive care (ACE inhibitors/ARBs), steroids or immunosuppressants for high‑risk patients, fish‑oil supplementation (controversial).
• Post‑infectious GN – usually self‑limited; manage hypertension and fluid status; antibiotics for the underlying infection.
• Lupus nephritis – high‑dose corticosteroids plus mycophenolate mofetil or cyclophosphamide; maintenance with azathioprine or belimumab.
• ANCA‑associated vasculitis – induction with IV methylprednisolone + rituximab or cyclophosphamide; maintenance with azathioprine or methotrexate.
• Alport syndrome – ACE inhibitors/ARBs slow progression; eventual renal transplantation when ESRD develops.
• Membranous nephropathy – supportive first; immunosuppression with rituximab or cyclophosphamide‑steroids if >8 g protein/day or declining GFR.

2. General Kidney‑Protective Measures

• Blood pressure control – target <130/80 mmHg; ACE inhibitors or ARBs are first‑line because they reduce proteinuria.
• Low‑salt diet – <2 g of sodium per day to limit fluid retention.
• Protein intake moderation – 0.8–1.0 g/kg/day for most CKD patients; individualized by a dietitian.
• Immunization – influenza, COVID‑19, and pneumococcal vaccines reduce infection‑related flares.
• Avoid nephrotoxins – NSAIDs, high‑dose contrast agents, and certain herbal supplements.

3. Home & Lifestyle Strategies

• Stay well‑hydrated (≈2 L water/day unless fluid‑restricted).
• Maintain a healthy weight and engage in regular aerobic activity (150 min/week).
• Quit smoking – smoking accelerates CKD progression.
• Monitor blood pressure at home and keep a log for your physician.

Prevention Tips

While you cannot prevent all causes (genetic disorders, autoimmune disease), many triggers can be mitigated:

• Prompt treatment of streptococcal infections – seek medical care for sore throat or skin sores; complete the prescribed antibiotic course.
• Vaccinations – reduce viral infections that can precipitate glomerulonephritis.
• Control diabetes and hypertension – primary drivers of secondary glomerular injury.
• Limit exposure to known nephrotoxins – avoid high‑dose NSAIDs, illicit drugs, and occupational chemicals (e.g., lead).
• Regular screening for at‑risk individuals – family members of patients with hereditary kidney disease should have annual urinalysis.
• Maintain good oral hygiene – periodontal disease has been linked to systemic inflammation affecting kidneys.

Emergency Warning Signs

Summary

Glomerular hematuria is a red‑flag sign that the filtering structures of the kidney are compromised. It can be an isolated, benign finding in hereditary thin‑basement‑membrane disease, or it can herald a serious, rapidly progressive glomerulonephritis. Early recognition, thorough evaluation, and cause‑directed therapy are essential to preserve kidney function and prevent chronic kidney disease.

Always discuss abnormal urine findings with a healthcare professional, especially if you have accompanying symptoms or known risk factors. Timely care not only addresses the immediate bleed but also uncovers potentially treatable systemic diseases.

---

References:

• Mayo Clinic. “Hematuria (blood in urine).” Accessed June 2024.
• National Kidney Foundation. “Glomerulonephritis.” Accessed June 2024.
• KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney International. 2023.
• Cleveland Clinic. “IgA Nephropathy.” Accessed June 2024.
• Centers for Disease Control and Prevention. “Post‑streptococcal Glomerulonephritis.” Accessed June 2024.

```